Publications:

miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma.

Oncogene

Cui, Tiantian T; Bell, Erica H EH; McElroy, Joseph J; Becker, Aline Paixao AP; Gulati, Pooja Manchanda PM; Geurts, Marjolein M; Mladkova, Nikol N; Gray, Ashley A; Liu, Kevin K; Yang, Linlin L; Liu, Ziyan Z; Fleming, Jessica L JL; Haque, S Jaharul SJ; Barnholtz-Sloan, Jill S JS; Ligon, Keith L KL; Beroukhim, Rameen R; Robe, Pierre P; Chakravarti, Arnab A

Publication Date: 2019-04

Variant appearance in text: HR: D252F

PubMed Link: 30559405

Variant Present in the following documents:

• Main text

View BVdb publication page

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.

Jama Oncology

Bell, Erica Hlavin EH; Pugh, Stephanie L SL; McElroy, Joseph P JP; Gilbert, Mark R MR; Mehta, Minesh M; Klimowicz, Alexander C AC; Magliocco, Anthony A; Bredel, Markus M; Robe, Pierre P; Grosu, Anca-L AL; Stupp, Roger R; Curran, Walter W; Becker, Aline P AP; Salavaggione, Andrea L AL; Barnholtz-Sloan, Jill S JS; Aldape, Kenneth K; Blumenthal, Deborah T DT; Brown, Paul D PD; Glass, Jon J; Souhami, Luis L; Lee, R Jeffrey RJ; Brachman, David D; Flickinger, John J; Won, Minhee M; Chakravarti, Arnab A

Publication Date: 2017-06-01

Variant appearance in text: HR: D252F

PubMed Link: 28097324

Variant Present in the following documents:

• Main text

View BVdb publication page